Skip to main content

SpeedPrecisionReliability

Take your scientific advancement to market with a full-service CDMO

Nucleus RadioPharma is an end-to-end contract development and manufacturing organization (CDMO) partner dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies so that radiopharmaceutical companies and other innovators can succeed.

Unlock your potential with our CDMO services

Targeted expertise for targeted radiotherapies

Under the rigorous scientific guidance of leading industry experts, we’re building the infrastructure radioligand therapy companies need to be successful at every stage to bring your products from concept to reality.

150
collective years experience in manufacturing
250
collective years experience in radiopharmaceutical supply chain

CDMO facilities designed specifically for radiotherapies

Every detail of our state-of-the-art, commercial-scale facilities is built with one purpose in mind: Advancing the development, manufacturing, and delivery of our clients’ radiotherapies quickly, efficiently, and safely.

Our Rochester, MN facility and upcoming Philadelphia, PA and Phoenix, AZ expansion sites uniquely equip us to mitigate current bottlenecks and bring your radiotherapeutics to market—and closer to patients—faster without sacrificing quality.

With our upcoming expansion sites, we’re scaling to over 100,000 square feet—purpose-built for radiopharmaceutical development and manufacturing—establishing one of the largest networks of its kind anywhere in the world.

  • Dedicated R&D space
  • Isotope agnostic
  • 21 CFR Part 210/211
  • ISO 13408-6
  • Current capacity:
    Up to 10,000 product vials per year
  • Future capacity:
    Additional 1.2M product vials per year

Go from breakthrough to reality

The potential for groundbreaking cancer treatments via targeted radiotherapies has grown, yet outdated processes and inefficiencies mar the path to bringing these solutions to market.

Our expert team is dedicated to helping innovators at every and any step of their journey to build robust and reliable clinical and commercial supply chains for targeted radiotherapies.

Nucleus Radiopharma radiopharmaceutical development lifecycle
CDMO services

Not every CDMO has the skills and resources to fit your unique needs.

We do.

Discover our services

Get a connected solution for complex supply chains

Challenges:
  • Manufacturing capacity has been a significant constraint for currently approved radioligand therapies, and with hundreds of new theranostics in clinical trials, the science has rapidly outpaced the supply chain.
  • The clock starts ticking from the moment the radioactive isotope is isolated and purified.
  • There may only be days, or sometimes even hours, to manufacture, release, ship, and administer a dose to a patient, making an effective delivery strategy crucial.
How Nucleus RadioPharma solves them:
  • Building our R&D and manufacturing facilities in proximity to prominent destination medical centers and key distribution hubs.
  • Offering flexible services so innovators can come to us at any point in their product lifecycle and receive optimal services to rapidly advance their program.
Outcomes:
  • More patients have access to life-extending treatments.
  • Fewer supply chain disruptions.
  • Accelerated path to commercialization while maintaining safety and quality.
radiopharmaceutical therapy scientist

Explore our radiopharmaceutical jobs

Blog

News & Events

Careers